⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13034698 | 1.00 | — | — | |
| SCHEMBL10036657 | 1.00 | — | — | |
| SCHEMBL10036656 | 1.00 | — | — | |
| SCHEMBL20390117 | 1.00 | — | — | |
| SCHEMBL15171197 | 1.00 | — | — | |
| SCHEMBL17196648 | 1.00 | — | — | |
| SCHEMBL20370084 | 0.85 | — | — | |
| SCHEMBL21066175 | 0.83 | — | — | |
| SCHEMBL13817255 | 0.83 | — | — | |
| SCHEMBL25585157 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8906871-B2 | MicromiRs | SANTARIS PHARMA A/S (DK) | 2014-12-09 | — | — | US | disclosed |
| US-20140288299-A1 | PROCESS | SANTARIS PHARMA A/S (DK) | 2014-09-25 | — | — | US | disclosed |
| US-8288356-B2 | MicroRNAs | SANTARIS PHARMA A/S (DK) | 2012-10-16 | — | — | US | disclosed |
| US-8288356-B2 | MicroRNAs | SANTARIS PHARMA A/S (DK) | 2012-10-16 | — | — | US | disclosed |
| US-20100298410-A1 | MICROMIRs | SANTARIS PHARMA A/S | 2010-11-25 | — | — | US | disclosed |
| US-20100004320-A1 | Pharmaceutical Composition | SANTARIS PHARMA A/S (DK) | 2010-01-07 | — | — | US | disclosed |
| US-20090143326-A1 | MICROMIRs | SANTARIS PHARMA A/S (DK) | 2009-06-04 | — | — | US | disclosed |
| US-20090143326-A1 | MICROMIRs | SANTARIS PHARMA A/S (DK) | 2009-06-04 | — | — | US | disclosed |